Infectious Dise rganism with the help of various diagnostic tools. Infectious disease conditions are highly prevalent in under developed regions due to lack of awareness for personal hygiene, minimal healthcare expenditures and absence of efficient physician services. The high incidence of infectious diseases across emerging economies formulate a major share in overall market. This has grab the attention of in vitro diagnostic device manufactures to invest into emerging economies. These companies are taking efforts to develop and commercialize cost effective tools for the infectious disease diagnosis. Presently, the gold standard tests available for bacterial infections and sexually transmitted disease diagnosis have major market share. However Roman Josi Jersey , these test are expected to replace by molecular techniques in future.
Infectious Disease Diagnostics Market: Drivers and Restraints
Increasing incidence of infectious disease, growing adoption of advanced molecular techniques, and increasing interventions from government and non-profile organization to reduce infectious disease in underdeveloped regions are endorsing the growth of infectious disease diagnosis market. In addition, the companies operating in the disease diagnostic technologies are focusing on the development of novel diagnostics, which eventually provides pace to the market growth. However Viktor Arvidsson Jersey , lack of awareness for novel diagnostic solution, absence of compiled regulatory guidelines and lower positivity rates due to inferior laboratory conditions would hinder the growth of infectious disease diagnostics market.
Based on condition, the global infectious disease diagnostics market is segmented into the following:
Bacterial Infection Viral Infection CNS infections Cardiovascular infection Fungal infection GI infections Sexually transmitted disease Other
Based on end use, the global infectious disease diagnostics market is segmented into the following:
Diagnostic laboratories Academic and medical institutes Contract Research Organization Hospitals and Surgical centers Ambulatory clinics Home healthcare
Infectious Disease Diagnostics Market: Overview
By test type Mattias Ekholm Jersey , the laboratory tests hold prominent share owing to its lower cost and easy availability. The emerging economies are the prime contributors of laboratory test segment especially in Asia-Pacific region, owing to high positivity rates. Laboratory test are first line of diagnostics referred by physicians which includes, blood test, urine test, spinal tap Colton Sissons Jersey , throat swabs, and stool test. By techniques, the molecular diagnostic techniques such as PCR, and other nucleic acid amplification test would gain prominence in developed region. Based on condition, the bacterial infections Kyle Turris Jersey , GI infections and Sexually transmitted disease have the largest share in infectious disease testing market, owing to high prevalence especially in emerging economies.
Request Free Report Sample@
Infectious Disease Diagnostics Market: Region-wise Outlook
Emerging economies such as India and China are the primary consumer for infection disease testing market, owing to growing urbanization which leads to unhygienic environment in the cities. Countries belongs to Asia-Pacific and Africa regions have largest share in infectious disease diagnosis market due to high prevalence and incidence of infectious diseases especially sexually transmitted disease and bacterial infections. North America and European countries will ahead towards the adoption on high end infectious disease diagnostic with the help of molecular technologies. This increasing adoption of premium diagnostic techniques would sustain the market share of infectious disease diagnostics in developed region.
Key companies operational in infectious diseases testing聽 market are Becton Dickinson & Company, Cepheid Inc., Abbott Laboratories Dan Hamhuis Jersey , BioMerieux, Hologic Inc., Bio-Rad Laboratories Inc., Danaher Corporation, Affymetrix Matt Duchene Jersey , Alere Inc., and DiaSorin. These companies are majorly focusing on getting approval for the commercialiation of their novel product launch. Recently, in 2015, Bio-Rad Laboratories, Inc. has got approval from US FDA for its BioPlex 2200 HIV Ag-Ab assay Ryan Johansen Jersey , which is used for HIV antigens and HIV antibodies.聽